Dr Amy Saik Yi Hsan
Funding in UTAR
- cytotoxicity of adriamycin and cytarabine on monocytic cells derived from leukemia-specific induced pluripotent stem cell, UTARRF, December 2019 - December 2020.
- anti-cancer properties of quercetin pegylated nanodiamonds in human colon cancer cells, UTARRF, December 2021 - December 2022.
- formulation, effectiveness and limitation of weight management products, DMS MEDHEALTH PLT (OLD NAME: DMS BEAUTY SOLUTIONS PLT), April 2022 - March 2026.
Funding not in UTAR
- development of quercetin pegylated nanodiamonds to inhibit tumor growth in colon cancer., UNIVERSITAS AIRLANGGA, June 2021 - June 2022.
- anti-cancer activity of inclusion complex plant bioactive compound with beta-cyclodextrin to the growth of colon cancer cells, UNIVERSITAS AIRLANGGA, May 2022 - May 2023.